1. Home
  2. GAIN vs CTKB Comparison

GAIN vs CTKB Comparison

Compare GAIN & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAIN
  • CTKB
  • Stock Information
  • Founded
  • GAIN 2005
  • CTKB 1990
  • Country
  • GAIN United States
  • CTKB United States
  • Employees
  • GAIN N/A
  • CTKB N/A
  • Industry
  • GAIN Finance: Consumer Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GAIN Finance
  • CTKB Health Care
  • Exchange
  • GAIN Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • GAIN 522.8M
  • CTKB 433.8M
  • IPO Year
  • GAIN 2005
  • CTKB 2021
  • Fundamental
  • Price
  • GAIN $13.98
  • CTKB $4.13
  • Analyst Decision
  • GAIN Buy
  • CTKB Hold
  • Analyst Count
  • GAIN 2
  • CTKB 4
  • Target Price
  • GAIN $14.00
  • CTKB $6.00
  • AVG Volume (30 Days)
  • GAIN 157.4K
  • CTKB 725.0K
  • Earning Date
  • GAIN 11-04-2025
  • CTKB 11-05-2025
  • Dividend Yield
  • GAIN 15.67%
  • CTKB N/A
  • EPS Growth
  • GAIN 8.96
  • CTKB N/A
  • EPS
  • GAIN 2.16
  • CTKB N/A
  • Revenue
  • GAIN $95,028,000.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • GAIN $6.54
  • CTKB N/A
  • Revenue Next Year
  • GAIN $4.49
  • CTKB $7.25
  • P/E Ratio
  • GAIN $6.49
  • CTKB N/A
  • Revenue Growth
  • GAIN 6.55
  • CTKB N/A
  • 52 Week Low
  • GAIN $11.42
  • CTKB $2.37
  • 52 Week High
  • GAIN $15.34
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • GAIN 54.46
  • CTKB 58.11
  • Support Level
  • GAIN $13.71
  • CTKB $4.00
  • Resistance Level
  • GAIN $14.06
  • CTKB $4.25
  • Average True Range (ATR)
  • GAIN 0.30
  • CTKB 0.19
  • MACD
  • GAIN 0.05
  • CTKB 0.03
  • Stochastic Oscillator
  • GAIN 97.23
  • CTKB 77.06

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: